Price-Gouging CEO and the Effects on For-Profit Pharma





Profit creates competition on a good day, on a bad day a 32 year old ex hedge fund guy under investigation hikes an AIDS drug from $13.50 to $750 to profit off the sick and taxpayers. This event raises the question: How do we avoid price-gouging on taxpayer subsidized items and how much profit and regulation belongs in drugs and treatments that treat chronic illness?